ULUATA DAYANÇ, B. Et Al. 2024. Pooled CRISPR Screening Identifies AP-1 Transcription Factor as a Druggable Driver of Osimertinib Resistance in Non-Small Cell Lung Cancer. The 2024 Annual Congress of the European Association for Cancer Research (EACR 2024) , (Rotterdam, Netherlands), 224.

ULUATA DAYANÇ, B., ERİŞ, S., ÇAKIROĞLU, E., Özden Yılmaz, G., Gülfırat, N. E., Coşkun, Ö. Ş., ... KARAKÜLAH, G.(2024). Pooled CRISPR Screening Identifies AP-1 Transcription Factor as a Druggable Driver of Osimertinib Resistance in Non-Small Cell Lung Cancer . The 2024 Annual Congress of the European Association for Cancer Research (EACR 2024) (pp.224). Rotterdam, Netherlands

ULUATA DAYANÇ, BENGİSU Et Al. "Pooled CRISPR Screening Identifies AP-1 Transcription Factor as a Druggable Driver of Osimertinib Resistance in Non-Small Cell Lung Cancer," The 2024 Annual Congress of the European Association for Cancer Research (EACR 2024), Rotterdam, Netherlands, 2024

ULUATA DAYANÇ, BENGİSU U. Et Al. "Pooled CRISPR Screening Identifies AP-1 Transcription Factor as a Druggable Driver of Osimertinib Resistance in Non-Small Cell Lung Cancer." The 2024 Annual Congress of the European Association for Cancer Research (EACR 2024) , Rotterdam, Netherlands, pp.224, 2024

ULUATA DAYANÇ, B. Et Al. (2024) . "Pooled CRISPR Screening Identifies AP-1 Transcription Factor as a Druggable Driver of Osimertinib Resistance in Non-Small Cell Lung Cancer." The 2024 Annual Congress of the European Association for Cancer Research (EACR 2024) , Rotterdam, Netherlands, p.224.

@conferencepaper{conferencepaper, author={BENGİSU ULUATA DAYANÇ Et Al. }, title={Pooled CRISPR Screening Identifies AP-1 Transcription Factor as a Druggable Driver of Osimertinib Resistance in Non-Small Cell Lung Cancer}, congress name={The 2024 Annual Congress of the European Association for Cancer Research (EACR 2024)}, city={Rotterdam}, country={Netherlands}, year={2024}, pages={224} }